Total Payments
$4,225
2024 Payments
$724.46
Companies
21
Transactions
234
Medicare Patients
14,289
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$3,847 (91.1%)
Education$377.98 (8.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,847 | 230 | 91.1% |
| Education | $377.98 | 4 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,129 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $485.67 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $449.88 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $438.73 | 24 | $0 (2024) |
| PFIZER INC. | $374.56 | 23 | $0 (2023) |
| GENZYME CORPORATION | $343.31 | 21 | $0 (2023) |
| Amgen Inc. | $314.40 | 18 | $0 (2024) |
| ABBVIE INC. | $200.46 | 11 | $0 (2024) |
| Lilly USA, LLC | $92.63 | 6 | $0 (2021) |
| LEO Pharma Inc. | $76.40 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $724.46 | 28 | SUN PHARMACEUTICAL INDUSTRIES INC. ($329.22) |
| 2023 | $895.20 | 42 | Sun Pharmaceutical Industries Inc. ($393.96) |
| 2022 | $672.31 | 35 | Sun Pharmaceutical Industries Inc. ($183.89) |
| 2021 | $591.11 | 37 | SUN PHARMACEUTICAL INDUSTRIES INC. ($137.74) |
| 2020 | $269.44 | 18 | PFIZER INC. ($75.44) |
| 2019 | $257.14 | 19 | Novartis Pharmaceuticals Corporation ($121.81) |
| 2018 | $439.13 | 32 | Novartis Pharmaceuticals Corporation ($147.67) |
| 2017 | $376.15 | 23 | GENZYME CORPORATION ($77.14) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Immunology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Immunology | ||||||
| 10/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.43 | General |
| 08/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Dermatology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $99.00 | General |
| 06/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Dermatology | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Dermatology | ||||||
| 04/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Dermatology | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,253 | 5,668 | $698,217 | $314,198 |
| 2022 | 21 | 3,213 | 5,494 | $664,603 | $308,433 |
| 2021 | 24 | 3,798 | 6,672 | $795,827 | $391,219 |
| 2020 | 22 | 4,025 | 7,151 | $828,360 | $360,978 |
Total Patients
14,289
Total Services
24,985
Medicare Billing
$1.4M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 670 | 1,025 | $96,401 | $59,075 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 442 | 691 | $96,262 | $58,261 | 60.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 451 | 600 | $87,000 | $47,152 | 54.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 180 | 303 | $121,200 | $37,776 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 292 | 341 | $46,717 | $20,816 | 44.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 64 | 75 | $29,625 | $16,965 | 57.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 376 | 488 | $50,882 | $15,746 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $25,200 | $11,756 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 146 | 146 | $21,170 | $9,644 | 45.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 62 | 75 | $32,850 | $7,897 | 24.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 277 | 1,573 | $31,460 | $7,673 | 24.4% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 31 | 32 | $12,960 | $7,666 | 59.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $6,800 | $4,152 | 61.1% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 30 | 30 | $21,630 | $3,378 | 15.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 60 | $4,200 | $2,339 | 55.7% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 18 | 18 | $9,648 | $2,046 | 21.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $1,650 | $992.10 | 60.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 21 | $1,596 | $829.74 | 52.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 42 | $966.00 | $35.07 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 580 | 953 | $132,467 | $80,639 | 60.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 480 | 621 | $90,045 | $50,210 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 564 | 839 | $78,866 | $47,378 | 60.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 126 | 220 | $91,600 | $27,764 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 396 | 500 | $52,530 | $16,940 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 232 | 273 | $37,401 | $16,823 | 45.0% |
About Dr. Ned Gross, M.D
Dr. Ned Gross, M.D is a Dermatology healthcare provider based in Martinsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346229127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ned Gross, M.D has received a total of $4,225 in payments from pharmaceutical and medical device companies, with $724.46 received in 2024. These payments were reported across 234 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,847).
As a Medicare-enrolled provider, Gross has provided services to 14,289 Medicare beneficiaries, totaling 24,985 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Martinsville, VA
- Active Since 01/11/2006
- Last Updated 08/13/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346229127
Products in Payments
- ILUMYA (Biological) $648.73
- DUPIXENT (Biological) $603.95
- COSENTYX (Biological) $323.72
- EUCRISA (Drug) $308.61
- TREMFYA (Drug) $253.94
- DUPIXENT (Drug) $178.09
- Otezla (Drug) $158.00
- Enbrel (Biological) $155.44
- REMICADE (Biological) $145.11
- RINVOQ (Biological) $113.31
- Ilumya (Biological) $94.79
- TALTZ (Drug) $92.63
- CIBINQO (Drug) $65.95
- ADBRY (Biological) $64.86
- ILUMYA (tildrakizumab-asmn) injection (Biological) $63.33
- COSENTYX (Drug) $59.46
- Tremfya (Drug) $55.66
- Humira (Biological) $54.77
- XOLAIR (Biological) $43.74
- OPZELURA (Drug) $38.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.